ArticleJournal of hematology & oncology2025

B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape.

Arne Van der Vreken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.